• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

基于络病理论探析肝纤维化“痰瘀互结”的病机演变及论治

通讯作者: 邓鑫, dx8848@126.com
DOI:10.12201/bmr.202610.00009
声明:预印本系统所发表的论文仅用于最新科研成果的交流与共享,未经同行评议,因此不建议直接应用于指导临床实践。

Corresponding author: dengxin, dx8848@126.com
  • 摘要:络病理论强调久病入络、痰瘀阻络及络阻成积的学术思想,与肝纤维化由功能失调逐渐进展至微循环障碍和组织结构重塑的病理演变特点具有内在契合性。本文以络病理论为切入点,结合现代肝纤维化病理机制,探讨痰、瘀在疾病进展中的相互影响及其阻滞、损伤肝络的过程,提出“痰瘀互结—络阻成积”是肝纤维化演变过程中重要病机主线,并据此从调肝健脾、痰瘀同治、逐瘀通络及软坚扶正等方面构建分期论治思路。旨在从络病视角重新认识肝纤维化的动态病机特点,为中医辨证分期及临床干预提供理论参考。

    关键词: 肝纤维化; 络病理论; 痰瘀互结; 络阻成积; 分期论治

     

    Abstract: Collateral disease theory emphasizes the pathological evolution of chronic disease involving the collaterals, obstruction of the collaterals by phlegm and blood stasis, and the eventual formation of accumulation due to persistent collateral obstruction. These concepts are consistent, at the level of pathological evolution, with the progression of liver fibrosis from functional dysregulation to microcirculatory disturbance and structural remodeling. Based on collateral disease theory and current understanding of the pathological mechanisms of liver fibrosis, this article explores the dynamic interactions among phlegm, blood stasis, and collateral dysfunction during disease progression. It proposes that “binding of phlegm and blood stasis followed by collateral obstruction and accumulation formation” represents a key pathological process in the evolution of liver fibrosis. Accordingly, a stage-oriented therapeutic approach is proposed, including eliminating pathogenic factors while regulating the liver and strengthening the spleen, simultaneously resolving phlegm and activating blood circulation, removing blood stasis and unblocking the collaterals, and softening accumulation while supporting healthy qi and nourishing the collaterals. This article provides a collateral disease–based perspective for understanding the dynamic pathogenesis of liver fibrosis and may offer a theoretical basis for syndrome differentiation, stage-oriented treatment, and clinical intervention in traditional Chinese medicine.

    Key words: : Liver fibrosis; Collateral disease theory; Phlegm and blood stasis binding; Collateral obstruction and accumulation formation; Stage-oriented treatment

    提交时间:2026-10-08

    版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
  • 图表

  • 莫震宇, 肖宇, 任颜, 曹秀萍, 谢军. 基于“虚气留滞”理论论治代谢相关脂肪性肝纤维化. 2026. doi: 10.12201/bmr.202606.00071

    高思悦, 谢瑶, 伍大华. 基于“三络失和、络损神伤”探讨脑小血管病伴抑郁的病机与辨治. 2026. doi: 10.12201/bmr.202610.00013

    李果, 董凤娇, 郭思源, 陈太全. “络息成积”视域下从“毒-虚-瘀”探析免疫检查点抑制剂相关心肌炎诊疗策略. 2026. doi: 10.12201/bmr.202609.00009

    李文强, 黄肖华. 基于“虚气留滞”理论从“虚、痰、瘀”论治非创伤性股骨头坏死. 2026. doi: 10.12201/bmr.202602.00041

    王春燕, 王其美, 贾慧彤, 祖迪, 胡栋楠. 基于“清浊升降”理论探讨特发性肺纤维化的发病机制与辨治思路. 2026. doi: 10.12201/bmr.202602.00072

    张燕玲, 陈启兰▲. 基于“痰瘀阻络、络风内动”理论论治冠状动脉痉挛的机制与临证思路. 2025. doi: 10.12201/bmr.202511.00087

    罗周青, 兰玲燕, 舒琦瑾. 从“络虚毒结”分期辨治肺癌治疗相关心悸经验. 2026. doi: 10.12201/bmr.202601.00067

    沈晓弋, 赵四林. 基于“亢害承制”分期论治特发性肺纤维化. 2026. doi: 10.12201/bmr.202602.00043

    龙本强, 曹阳. 从“虚、瘀、痰、毒”论治糖尿病性骨折愈合迟缓. 2026. doi: 10.12201/bmr.202603.00007

    罗姝, 杨宗亮, 罗敏. 基于《内经》“汁沫与血相抟”理论论治结直肠息肉. 2024. doi: 10.12201/bmr.202412.00046

  • 序号 提交日期 编号 操作
    2 2026-09-22

    10.12201/bmr.202610.00009V2

    下载
    1 2026-09-22

    10.12201/bmr.202610.00009V1

    下载
  • 公开评论  匿名评论  仅发给作者

引用格式

黄勇斌, 邓鑫. 基于络病理论探析肝纤维化“痰瘀互结”的病机演变及论治. 2026. biomedRxiv.202610.00009

访问统计

  • 阅读量:25
  • 下载量: 0
  • 评论数:0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误